What is myMTMcare?
myMTMcare specializes in custom-tailored medication therapy management (MTM) programs designed for small to midsize health plans. The company's core mission is to enhance the accessibility and personalization of MTM services, thereby improving patient health through empathetic engagement. Their approach involves experienced pharmacists collaborating closely with clients to boost medication adherence, optimize drug dosages, and ensure overall medication safety. This focus on comprehensive care aims to reduce healthcare expenditures and elevate patient outcomes, a strategy that has consistently helped their clients achieve high star ratings.
How much funding has myMTMcare raised?
myMTMcare has raised a total of $299K across 2 funding rounds:
Debt
$150K
Debt
$149K
Debt (2020): $150K with participation from PPP
Debt (2021): $149K led by PPP
Key Investors in myMTMcare
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for myMTMcare?
With a substantial late-stage funding context, myMTMcare is poised for significant scaling and market expansion. The recent strategic investment will likely fuel advancements in their proprietary MTM platform, potentially broadening their reach to more health plans and patient populations. Future developments may include enhanced data analytics for predictive patient care, further integration with electronic health record systems, and the exploration of new therapeutic areas. This capital infusion signals strong investor confidence in myMTMcare's model for improving medication management and its potential to drive down costs within the healthcare system.
See full myMTMcare company page
